Evaluating commercial multimodal AI for diabetic eye screening and implications for an alternative regulatory pathway.
PMID : 41398461 ·
M, a, t, t, h, e, w, , S, , H, u, n, t, ;, , T, i, n, g, l, o, n, g, , D, a, i, ;, , M, i, c, h, a, e, l, , D, , A, b, r, à, m, o, f, f
Publicité
Résumé
Autonomous AI for diabetic eye examination is among the most validated and trusted medical AI systems, supported by extensive real-world evidence demonstrating safety, efficacy, improved outcomes, increased productivity, and cost savings. Yet its adoption remains limited. In contrast, commercially available off-the-shelf generative AI models (OTSAIs) are being rapidly tested in medical settings despite a lack of such real-world validation. These models have shown strong performance on medical re
Publicité
Source officielle
Voir sur PubMed →Données issues de PubMed / NCBI. Pour le texte intégral et les informations les plus récentes, consultez toujours la notice officielle.